Selected passages from the FDA letter
Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.
Passage 1Your Mood Support product is not generally recognized as safe and effective for the above referenced uses and, therefore, this product is “new drug” under section 201(p) of the Act [21 U.S.C. § 321(p)].
Passage 2Accordingly, your Mood Support product fails to bear adequate directions for their intended use and, therefore, the product is misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)].
Citations in the original letter
As cited in this historical letter, not a statement of current regulatory requirements.
- 21 CFR 201.5